Targeting mutant p53: Evaluation of novel anti-p53R175H monoclonal antibodies as diagnostic tools
Abstract About 50% of all cancers carry a mutation in p53 that impairs its tumor suppressor function. The p53 missense mutation p53R175H (p53R172H in mice) is a hotspot mutation in various cancer types. Therefore, monoclonal antibodies selectively targeting clinically relevant mutations like p53R175...
Saved in:
Main Authors: | Diana Spiegelberg, Le-Ann Hwang, Khian Hong Pua, Sashwini Chandra Kumar, Xin Yu Koh, Xiao Hui Koh, Ram Kumar Selvaraju, Kanaga Sabapathy, Marika Nestor, David Lane |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-024-83871-w |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The relationship between IDH, P53 mutations, MGMT methylation with characteristics in high grade glioma patients
by: Duc Anh Tran, et al.
Published: (2022-07-01) -
Side-stepping the guardian of the genome: current cancer therapeutics targeting mutant p53
by: Iulianna C. Taritsa, et al.
Published: (2025-01-01) -
A sequencing-based method for quantifying gene-deletion mutants of bacteria in the intracellular environment
by: Xiao Fei, et al.
Published: (2025-01-01) -
Immunohistochemical evaluation of P53 in squamous cell carcinoma of the esophagus
by: Kala K, et al.
Published: (2024-10-01) -
Smad1 Promotes Tumorigenicity and Chemoresistance of Glioblastoma by Sequestering p300 From p53
by: Lingli Gong, et al.
Published: (2025-01-01)